Digest Network Come funziona
Network
/
Società
En
Non verificato

Encoded Therapeutics Inc.

Di cosa scriviamo

BiotecnologiaFarmaceuticaIndustriaMedicina - VarieSalute

8 comunicati stampa

Guarda tutti i comunicati
05/12/2025
Scienza
Farmaceutica
Vetrine/Shopping
Biotecnologia
Infanzia
Medicina - Varie
Assistenza all'Infanzia
Igiene alimentare
Salute
Eventi
Industria
Encoded Therapeutics Presents Positive Interim Efficacy Data from Initial Dose Levels of Phase 1/2 Trials Evaluating ETX101 Gene Therapy in Dravet Syndrome
Fonte
Encoded Therapeutics Inc.
Emittente
Business Wire
1.00
0
01/12/2025
Scienza
Igiene alimentare
Biotecnologia
Medicina - Varie
Salute
Farmaceutica
Sanità
Eventi
Industria
Encoded Therapeutics to Present Interim Phase 1/2 Clinical Data on ETX101, the First One-time Gene Therapy in Development for Dravet Syndrome, at the 2025 American Epilepsy Society Annual Meeting
Fonte
Encoded Therapeutics Inc.
Emittente
Business Wire
1.00
0
09/10/2025
Scienza
Biotecnologia
Medicina - Varie
Sanità
Farmaceutica
Salute
Industria
New Preclinical Data from Encoded Therapeutics Demonstrate Therapeutic Potential of its One-time, Non-opioid Gene Therapy Candidate for Chronic Pain
Fonte
Encoded Therapeutics Inc.
Emittente
Business Wire
1.00
0
02/09/2025
Salute
Igiene alimentare
Biotecnologia
Medicina - Varie
Farmaceutica
Industria
Encoded Therapeutics Announces Regenerative Medicine Advanced Therapy (RMAT) Designation Granted by U.S. FDA for ETX101 in SCN1A+ Dravet Syndrome
Fonte
Encoded Therapeutics Inc.
Emittente
Business Wire
1.00
0
13/05/2025
Eventi
Industria
Psichiatria
Scienza
Biotecnologia
Medicina - Varie
Salute
Farmaceutica
Encoded Therapeutics Presents Promising New Data for CNS Gene Therapy Programs at the ASGCT 28th Annual Meeting
Fonte
Encoded Therapeutics Inc.
Emittente
Business Wire
1.00
0
28/04/2025
Eventi
Fiere
Biotecnologia
Farmaceutica
Salute
Encoded Therapeutics to Present New Data for CNS Gene Therapy Programs at the ASGCT 28th Annual Meeting
Fonte
Encoded Therapeutics Inc.
Emittente
Business Wire
1.00
0
13/02/2025
Biotecnologia
Salute
Farmaceutica
Medicina - Varie
Industria
Encoded Therapeutics Reports Clinical Progress of ETX101 Gene Therapy for Dravet Syndrome, Recaps 2024 Corporate Achievements and Provides 2025 Outlook
Fonte
Encoded Therapeutics Inc.
Emittente
Business Wire
1.00
0
07/11/2024
Eventi
Industria
Scienza
Biotecnologia
Medicina - Varie
Sanità
Salute
Farmaceutica
Encoded Demonstrates Therapeutic Potential of a Vectorized miRNA-based Approach for Angelman Syndrome at the FAST Annual Global Science Summit
Fonte
Encoded Therapeutics Inc.
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0